Farm Animal Drugs Market is expected to reach US$ 29.4 Billion by 2032

The global farm animal drugs market is estimated to be worth US$ 17.2 billion by the end of 2022, and to grow at a 5.5% CAGR from 2022 to 2032. By the end of 2032, the market is expected to be worth US$ 29.4 billion. In terms of animals, livestock animals are the market leader, accounting for around 92.4% of the market in 2021.

To remain ahead of your competitors, request for a sample@ https://www.futuremarketinsights.com/reports/sample/rep-gb-2402

Omnivores are directly dependent on healthy, productive animals for food and financial stability, particularly in low- and middle-income countries where a substantial number of people make a living by rearing animals. According to the Health for Animals Organization, 1.3 billion people globally keep livestock (2021). As a result, regulating and preventing animal diseases is critical to attaining the SDGs and provides a global public benefit.

Antibiotics are also routinely used to treat ill animals. Failure to adhere to drug withdrawal periods in farm animals results in contaminated goods, raising questions about their safety when consumed by humans. Items containing more than a particular amount of antibiotic residue are considered inappropriate for ingestion and should be disposed of in a way that minimises the risk of environmental contamination.

Antimicrobial-resistant bacteria can be transmitted to humans either directly or indirectly through contaminated environments, tainted foods, or direct contact with animals. These considerations are expected to push pharmaceutical companies to create novel farm animal medications.

US Farm Animal Drugs Market

The United States dominates the North American area, with a farm animal Drugs market share of approximately 56.5% in 2021. According to FMI, the country is anticipated to maintain its current growth rate during the forecast year. Rising prevalence of numerous animal diseases caused by increased globalisation, strong demand for meat exports from the United States, and antibiotic resistance in animals are expected to drive important stakeholders in the country to produce breakthrough farm animal medications.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert@ https://www.futuremarketinsights.com/ask-question/rep-gb-2402

Germany Farm Animal Drugs Market

In 2021, Germany owned a 2.7% share of the worldwide farm animal medicines market. Stringent legislation restricting the use of antibiotics to increase farm animal productivity is one factor affecting antibiotic sales in the country. The majority of cattle production in Germany is highly industrialised and modernised, with increasing percentages of output employing various biosecurity measures and disease-threat reduction strategies. Regulations or consumer pressures have encouraged the country to adopt disease-reduction initiatives, which would boost the German farm animal medicine industry.

Competitive Landscape

Key companies profiled in the report are Bayer AG, Boehringer Ingelheim GmbH, Zoetis, Inc.,  Ceva Santé Animale, Dechra Drugs PLC, Elanco Animal Health (Sub. Eli Lilly), Merck Animal Health, Virbac SA, Vetoquinol SA, Intas Animal Health, Alembic Animal Health, Sequent Scientific, Hester Biosciences, Ashish Life Sciences,  Ouro Fino Saude Animal (Ourofino), Zydus Animal Health (Sub. Cadila Healthcare Ltd), Phibro Animal Health Corporation,  Nippon Zenyaku Kogyo Co., Ltd, Norbrook, Kyoritsu Seiyaku Corporation.

Market segmentation

A good market segmentation always covers the vitals in that particular market to arrive at important decisions. In the case of the farm animal drugs market, an all-inclusive research segmentation can be seen.

Buy Now@ https://www.futuremarketinsights.com/checkout/2402

Product Type

• Anti-Infective
• Parasiticides
  • Endo-parasiticides
  • Ecto-parasiticides
  • Endectocides
• Anti-inflammatory
• Anesthetics
• Analgesics
• Hormones and related products
• Others

Animal Type

• Livestock Animals
  • Ruminants
  • Swine
  • Poultry
• Equine

Route of Administration

• Oral
• Parenteral
• Topical
• Others

Distribution Channel

• Veterinary Hospitals
• Veterinary Clinics
• Pharmacies and Drug Stores
• Others

About Future Market Insights (FMI)

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs